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ABSTRACT
Objective: To assess the impact of proctoring for
chronic total occlusion (CTO) percutaneous coronary
intervention (PCI) in six UK centres.
Methods: We retrospectively analysed 587 CTO
procedures from six UK centres and compared success
rates of operators who had received proctorship with
success rates of the same operators before proctorship
(pre-proctored) and operators in the same institutions
who had not been proctored (non-proctored). There
were 232 patients in the pre-proctored/non-proctored
group and 355 patients in the post-proctored group.
Complexity was assessed by calculating the Japanese
CTO (JCTO) score for each case.
Results: CTO PCI success was greater in the post-
proctored compared with the pre-proctored/non-
proctored group (77.5% vs 62.1%, p<0.0001). In more
complex cases where JCTO≥2, the difference in
success was greater (70.7% vs 49.5%, p=0.0003).
After proctoring, there was an increase in CTO PCI
activity in centres from 2.5% to 3.5%, p<0.0001 (as a
proportion of total PCI), and the proportion of very
difficult cases with JCTO score ≥3 increased from
15.3% (35/229) to 29.7% (105/354), p<0.0001.
Conclusions: Proctoring resulted in an increase in
procedural success for CTO PCI, an increase in
complex CTO PCI and an increase in total CTO PCI
activity. Proctoring may be a valuable way to improve
access to CTO PCI and the likelihood of procedural
success.
INTRODUCTION
Success rates for chronic total occlusion
(CTO) percutaneous coronary intervention
(PCI) in published series have increased by
an average of 1% per year from 68% in 2000
to 79% by 2011.1 The impact of any develop-
ment on success rate may be reduced by the
tendency for operators to take on more chal-
lenging cases.2 However, in the absence of
an increase in CTO PCI as a proportion of
total PCI activity in national registries, it
seems unlikely that there has been a wide-
spread increase in case complexity in the
last decade. There are large differences in
KEY MESSAGES
What is already known about this subject?
▸ Although high success rates for chronic total
occlusion (CTO) percutaneous coronary inter-
vention (PCI) have been reported in small series,
these have proved challenging to reproduce in
broader populations.
▸ A systematic approach to angiographic assess-
ment and procedural strategy termed the hybrid
approach has been associated with high proced-
ural success.
▸ The hybrid approach requires training in ante-
grade wire escalation, antegrade dissection
re-entry and the retrograde approach.
What does this study add?
▸ Before engagement in a systematic training pro-
gramme, there is evidence of case selection bias
with low levels of procedural success evident in
more complex cases.
▸ Following engagement in a training programme,
which included one-to-one proctoring, we identi-
fied a large increase in CTO PCI success in six
UK interventional units.
▸ The increase in success is greatest in the most
complex cases. Following proctorship, there was
less suggestion of selection bias with an
increase in case complexity and with CTO PCI
activity representing a higher proportion of total
PCI activity.
How might this impact on clinical practice?
▸ Our data support engagement in a systematic
training programme for CTO PCI, which includes
onsite proctoring.
▸ Referral of ‘complex’ CTOs to a dedicated CTO
service with operators proficient in retrograde
and antegrade dissection re-entry techniques is
likely to offer better procedural success, particu-
larly in more complex cases.
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attempt rates between centres performing CTO PCI,
which are difﬁcult to resolve scientiﬁcally and which may
reﬂect variation in operator expertise.3 The Japanese
CTO ( JCTO) score provides the most widely accepted
measure of technical complexity, but has been recently
introduced and is not routinely recorded in most regis-
tries.4 As case complexity increases, conventional wire
techniques become less successful and less efﬁcient,5
with a consequently higher need for retrograde techni-
ques and techniques which use blunt dissection to nego-
tiate long, tortuous or calciﬁed occlusions.6 The relative
complexity of these methods and previous lack of a sys-
tematic approach to CTO PCI may explain why these
techniques have remained concentrated in the hands of
a limited number of CTO experts.
The hybrid approach to CTO PCI is a novel, systematic,
algorithm-led PCI strategy based on the identiﬁcation of
key angiographic features and the ability to utilise newer
PCI approaches, including antegrade dissection re-entry
(ADR) and retrograde dissection re-entry (RDR) techni-
ques.7 The algorithm was designed to be easily teachable
and reproducible, contrasting with traditional wire-based
approaches, which rely on individual operator skill and
‘feel’. To ensure appropriate use, access to dedicated dis-
section re-entry devices (Crossboss; Stingray; Boston
Scientiﬁc, USA) has been restricted to centres that have
engaged in a training programme. We aimed to assess the
impact of this by retrospective analysis of success rates for
CTO PCI in six UK centres, Glasgow, Newcastle, Bristol,
Bournemouth, Essex and Nottingham, before and after
their engagement in this training programme.
METHODS
All centres received a minimum of three proctoring visits
with some operators visiting their proctor’s centre for
additional experience. Proctors were expert CTO PCI
operators with a career experience of over 750 CTO PCI
procedures, including over 100 retrograde and 100 ADR
cases. When proctors visited, cases were scheduled to
allow sufﬁcient time with alternative cover arranged for
emergency cases.8 All participating operators were
experienced interventional cardiologists in practice for a
median of 8 years undertaking a median of 325 PCI cases
annually. All operators attended at least 2 days of didactic
teaching and live case review and were encouraged to
visit a website containing source material and case studies
(http://www.ctofundamentals.org). A systematic audit of
all CTO procedures in these centres was undertaken over
periods of 6–12 months before and after periods of proc-
toring. Cases undertaken jointly with the proctors were
not included. Cases were identiﬁed from data routinely
reported to the British Cardiovascular Intervention
Society (BCIS) national database as CTOs and validated
by review of the angiograms and clinical records. Cases
not meeting the criteria for ‘true’ or ‘functional’ occlu-
sion, or whose occlusion was likely to have been in the
past 3 months, were excluded.
Pooled patient level data including technique used in
CTO PCI for sequential patients who underwent CTO
PCI at these six different Cardiology centres were
analysed.
Operators were described as ‘post-proctored’ after
they had undertaken CTO PCI jointly with a proctor as
part of a training programme in hybrid CTO PCI and
‘pre-proctored’ before they had done so. Operators were
described as ‘non-proctored’ if they had never been
proctored by an expert in CTO PCI. Patients were
divided into two ‘groups’ based on whether the operator
was pre-proctored/non-proctored or post-proctored.
The JCTO score was calculated for all cases by an inde-
pendent observer, not the operator. The successful strat-
egy was categorised as antegrade wire escalation (AWE),
ADR (either with knuckle wire and wire-based re-entry or
dedicated device, eg, CrossBoss and Stingray) or retro-
grade (Retro—either retrograde wire escalation or RDR).
Statistical analysis
Statistical analysis was performed using SPSS V.20.
Missing values for demographic variables were replaced
by median of the nearest neighbour. No variable had
missing values >5%. Demographics, success rates and
techniques were compared between the two groups.
Continuous variables are presented as mean (±SD) and
categorical variables as percentage. The χ2 test or
Fisher’s exact test was utilised for testing the difference
between categorical variables and Student t test for asses-
sing the difference between means. Results were consid-
ered statistically signiﬁcant if p was <0.05.
A propensity score was derived by modelling a logistic
regression analysis with ‘proctored or not’ as the
dependent variable and the following factors as indica-
tors: age, gender, diabetes mellitus, hypertension, hyper-
cholesterolaemia, smoker, renal impairment (creatinine
>200 μmol/L), previous coronary artery bypass grafting
(CABG), previous cerebrovascular event, objective evi-
dence of ischaemia, presenting clinical syndrome (stable
angina), previous failed CTO PCI, radial access, dual
access, use of newer tools (CrossBoss, Stingray, Tornus or
Corsair Microcatheter), retrograde approach and the
JCTO score (≥2 or not). This derived propensity score
was used as a variable along with ‘has been proctored’ as
a second variable in a regression (covariance) adjust-
ment to adjust for confounding factors and identify pre-
dictors of PCI success. In addition, cross tabulation was
undertaken to demonstrate association between proctor-
ing and PCI success by JCTO scores.
RESULTS
A total of 587 patients with true CTOs were included in
the analysis. In total, 232 patients were in the non-
proctored/pre-proctored group and 355 patients in the
post-proctored group. Limited technical details were
available for three patients in the pre-proctored/non-
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proctored group and one patient in the post-proctored
group.
In total, 19.4% of total patients were female and
22.5% had diabetes mellitus. Other demographics and
procedural characteristics are illustrated in table 1.
The proctored group had signiﬁcantly more overall
success compared with the pre-proctored/non-proctored
group (77.5% vs 62.1%, respectively, p<0.0001). This was
driven mainly by an increase in success rate in patients
with JCTO scores ≥2 (70.7% vs 49.5%, p=0.0003, respect-
ively, ﬁgure 1). Success in patients where an attempt at
PCI had previously been unsuccessful was 75% in the
post-proctored group and 44% in the pre-proctored/
non-proctored group (p=0.004).
Very similar demographics were observed in the two
‘groups’ but there were a higher proportion of patients
with a history of CABG (16.3% vs 9.5%, p=0.019) and
previous failure (29.4% vs 11.6%, p=0.019) in the post-
proctored group. The proportion of lesions with JCTO
scores ≥3 and ≥4 was signiﬁcantly greater in the post-
proctored group (table 2).
Proctoring was a signiﬁcant indicator of CTO PCI
success as demonstrated by regression analysis (OR=0.47,
p<0.001, 95% CI (0.33 to 0.67)). Cross tabs demon-
strated a moderate but signiﬁcant association of PCI
success if the operator had been proctored, especially in
patients with JCTO scores ≥2 (Phi, Cramer’s V and
Contingency coefﬁcient all >0.2). In the post-proctored
period, the amount of CTO PCI as a proportion of each
centre’s total PCI activity increased from 2.5% to 3.5%
(p<0.0001, table 3).
Procedures in the post-proctoring group had higher
radiation doses (16 386 vs 10 400.5 cGy/m2, p<0.0001) and
greater contrast use (299 vs 254 mL, p<0.0001; table 1).
There was no signiﬁcant difference in complications
recorded in between the two groups (table 4).
DISCUSSION
We report the ﬁrst systematic attempt to identify the
impact of a dedicated teaching programme and a novel
treatment algorithm on case selection and subsequent
procedural success in CTO PCI. Technical success for
CTO PCI increased after proctoring from a mean of
62–78% at the six centres.
Concurrently, the case mix evolved such that signiﬁ-
cantly more difﬁcult CTOs were treated, including a
greater proportion of patients with prior CABG, a factor
which has previously been associated with lower proced-
ural success.9 Furthermore, we observed an increase in
the total proportion of CTO PCI being undertaken in
contrast to national trends during the same period.
These observations are consistent with CTO operators
undertaking greater numbers of unselected cases, yet
Table 1 Demographics and CTO PCI details
Variable
Pre-proctored/
non-proctored group
N=232
Post-proctored
group
N=355
Significance
(p Value)
Age (mean±SD) 65±11.55 65±11.36 1.00
Female gender (%) 51 (22%) 63 (17.7%) 0.24
HTN (%) 164 (70.7%) 246 (69.3%) 0.78
DM (%) 52 (22.4%) 80 (22.5%) 1.00
Hypercholesterolaemia (%) 81 (34.9%) 107 (30.1%) 0.24
Previous CVA (%) 15 (6.5%) 19 (5.4%) 0.47
Previous CABG (%) 22 (9.5%) 58 (16.3%) 0.019
Renal impairment (creatinine ≥200 mmol/L) (%) 4 (1.7%) 9 (2.5%) 0.58
Smoker (%) 76 (32.7%) 118 (33.2%) 0.92
Stable angina (%) 188 (81%) 316 (89%) 0.008
Success overall (%) 144/232 (62.1%) 275/355 (77.5%) <0.0001
JCTO≥2* (%) 115/229 (50.2%) 205/354 (57.9%) 0.07
Success in JCTO≥2 (%) 57/115 (49.6%) 145/205 (70.7%) 0.0003
Previous CTO PCI failure (%) 27 (11.6%) 104 (29.3%) <0.001
Success in previous failure 12/27 (44.4%) 78/104 (75%) 0.004
Complications (%) 15/232 (6.5%) 30/354 (8.5%) 0.42
Dual access (%) 67/232 (28.9%) 242/355 (68.2%) <0.0001
Contrast load (mL)* 254±105.8† 299±118.4† <0.0001
Fluoroscopy dose (cGy/m2)* 10 400.5±7589.32‡ 16 386.1±19 750.8‡ <0.0001
Screening time (min)* 39.06±18.45§ 42.28±25.07§ 0.096
*Missing values not replaced.
†Data for 228 patients in non-proctored/pre-proctored and 346 patients in proctored group.
‡Data for 228 non-proctored/pre-proctored and 342 post-proctored patients.
§Data for 229 pre-proctored/non-proctored and 343 post-proctored patients.
CABG, coronary artery bypass grafting; CTO, chronic total occlusion; CVA, cerebrovascular accident; DM, diabetes mellitus; HTN,
hypertension; JCTO, Japanese CTO; PCI, percutaneous coronary intervention.
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delivering higher procedural success after proctoring.
The improvement in technical success following proctor-
ing is greatest in more complex CTO PCI cases ( JCTO
score ≥2), where a 21% greater success rate was found.
Lesion complexity is a strong marker for increased CTO
crossing time, decreased success rates4 and need for
blunt dissection techniques whether from an antegrade
or retrograde direction.6 In less complex lesions, AWE is
more likely to be successful as a primary strategy, and as
these techniques are most analogous to standard PCI,
success rates are generally ‘better’ with less room for
improvement. Despite this, a signiﬁcant effect was
identiﬁed.
Perhaps, the greatest difference in success rates is seen
in cases where there has been a previous failure. In this
category of lesion, proctored operators experienced a
success rate 31% higher than the non-proctored/pre-
proctored operators. The majority of ﬁrst attempts are
with AWE, and therefore, the availability of another strat-
egy in these cases is particularly helpful, as factors pre-
disposing to failure using this technique often remain
present at the time of a subsequent procedure.
It would be simplistic to assert that proctoring in isola-
tion is sufﬁcient to achieve this degree of improvement in
success. Concurrent with proctoring, our centres gained
access to new devices and the hybrid approach to CTO
PCI was becoming more widely accepted. Although the
desire to use the CrossBoss and Stingray dissection
re-entry devices may have been the stimulus to engage
with a proctor, it is important to note that proctoring for
CTO PCI has not been based on a particular ‘device’, but
rather the integration of a number of enabling techni-
ques and technologies.10 Operators and centres who
organised proctoring also had a particular interest in
developing CTO programmes and prior to proctoring
attended specialist meetings and used other online edu-
cational resources. Nevertheless, such educational oppor-
tunities have been available for many years without such
a marked improvement in success. It is therefore likely
that for those with signiﬁcant pre-existing experience and
knowledge, the proctoring visits act to consolidate learn-
ing and facilitate the transition from knowledge to prac-
tice. The relative effects of proctoring versus technology
and theoretical knowledge are most readily separated in
Table 2 Proportion of cases with JCTO scores ≥2
pre-proctoring/non-proctoring and post-proctoring
JCTO
score
Pre-proctored/
non-proctored Post-proctored Significance
≥2 115/229 (50.2%) 205/354 (57.9%) 0.07
≥3 35/229 (15.3%) 105/354 (29.7%) <0.0001
≥4 5/229 (2.2%) 42/354 (11.9%) <0.0001
=5 1/229 (0.4%) 6/354 (1.7%) 0.3
JCTO, Japanese CTO.
Figure 1 Success rates for procedures undertaken by pre-proctored/non-proctored and post-proctored operators categorised
according to JCTO score. JCTO score 0/1 implies easy or moderate and JCTO score ≥2 implies difficult or very difficult. In each
bar successful procedures are further categorised by final successful strategy. The proctored group had significantly more overall
success compared with the pre-proctored/non-proctored group (77.5% vs 62.1%, respectively, p<0.0001). This was driven mainly
by an increase in success rate in patients with JCTO≥2 (70.7% vs 49.5%, p=0.0003). JCTO, Japanese chronic total occlusion;
AWE, antegrade wire escalation; ADR, antegrade dissection re-entry; RETRO, retrograde.
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the subgroup of retrograde procedures. The theoretical
knowledge from meetings and equipment was already in
place before proctoring started. After proctoring, use of
the retrograde approach increased threefold from 9.5%
to 29.9% along with a signiﬁcant increase in retrograde
success from 36% to 59%.
While success rates of 78% cannot compare with the
best reported series from expert operators,7 we have
identiﬁed a 16% absolute increase in success over a
median period of 7 months. The annual increase in
success of 0.4% reported by BCIS audit ﬁgures would
suggest that operators might work their entire careers
relying on experiential learning and specialist meetings
without achieving the same increase in success demon-
strated after three visits from a proctor.
CTO PCI involves progression through a number of
discrete steps. The later stages (RDR, externalisation,
re-entry with Stingray system) can only be attempted
after success of the preceding stages (retrograde access,
successful crossing with knuckle wire or CrossBoss
catheter).
The presence of a proctor to guide or even personally
undertake a particularly challenging stage enables the
case to progress safely to the point when experience can
be gained on the ﬁnal stages.
If a case fails at an earlier stage, this experience in the
later stages is lost and a greater number of cases are
required for competency in the later stages to be
reached.
AWE success accounted for a lower proportion of suc-
cessful procedures after proctoring. One explanation
might be that proctored operators were looking for
opportunities to use new techniques and technologies,
when a simpler strategy could have been successful if
given more time. While our data cannot disprove this,
we believe a more likely explanation may lie in the dif-
ferences in case mix, with a greater number of previous
failures and post-CABG patients in the post-proctored
group. These factors suggest a greater technical com-
plexity and a lower likelihood of success with AWE.
The proportion of cases treated successfully by AWE
was 57% before proctoring and 48% after proctoring.
This compares to 50% of cases successfully completed
by AWE in the US Hybrid registries.11 This proportion
falls lower still in case series where there is a higher pro-
portion of difﬁcult cases.7 In this series (where the pro-
portion of cases with JCTO score ≥2 was 89%) only 34%
of successful cases were treated by AWE.
Limitations
There are a number of potential limitations with this
study. Validation of CTOs, assessment of success and cal-
culation of JCTO score has been undertaken in the
centre where PCI was performed rather than at a single
core laboratory. Nevertheless, a single observer, inde-
pendent to the operator, was responsible for angio-
graphic analysis and data collection of pre-proctored
and post-proctored data in each centre. As a retrospect-
ive study, we have relied on routine clinical data collec-
tion to capture complications, which may therefore be
under-reported. We cannot control for operators defer-
ring treatment of ‘ideal’ cases until after appropriate
Table 4 Recorded CTO PCI complications
Complications
Pre-proctored/
non-proctored Post-proctored
Coronary 10 (4.3%) 13 (3.7%)
Ventricular fibrillation 1 (0.4%) 0 (0%)
Femoral access
haematoma
1 (0.4%) 4 (1.1%)
Aorto-ostial dissection 2 (0.9%) 1 (0.3%)
Side branch occlusion 0 (0%) 2 (0.6%)
Donor vessel
thrombosis
0 (0%) 1 (0.3%)
Retroperitoneal bleed 0 (0%) 4 (1.1%)
Death 1 (0.4%) 2 (0.6%)
Transient ischaemic
attack
0 (0%) 1 (0.3%)
Femoral dissection 0 (0%) 1 (0.3%)
Total 15/232 (6.5%) 30/354 (8.5%)
CTO, chronic total occlusion; PCI, percutaneous coronary
intervention.
Table 3 CTO PCI as a proportion of total for each centre
Centre
Total PCIs
pre-proctored/
non-proctored
Pre-proctored/
non-proctored
CTO PCIs attempted
Total PCIs
post-proctored
Post-proctored
CTO PCIs attempted
Centre 1 2633 29 (1.1%) 2170 28 (1.3%)
Centre 2 2756 82 (3%)
(2 operators)
2681 130 (4.8%)
(2 operators)
Centre 3 589 13 (2.2%) 1403 47 (3.3%)
Centre 4 878 15 (1.7%)
(1 operator)
871 17 (2%)
(1 operator)
Centre 5 1388 36 (2.6%) 2061 74 (3.6%)
Centre 6 490 44 (9%) 979 59 (6%)
All centres 8734 219 (2.5%) 10 165 355 (3.5%)
CTO, chronic total occlusion; PCI, percutaneous coronary intervention.
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‘training had been received’, but we believe this is
unlikely as the most favourable cases were generally
selected as ‘training’ cases when the proctors visited.
Our attempt to assess the impact of proctorship on the
revascularisation rates of patients with CTOs is limited as
we do not have validated CTO data from non-proctored
operators from every centre. We will, therefore, have
underestimated the overall CTO PCI ‘rate’ but believe
the relative increase that we observe following proctor-
ship to be valid.
Summary
We have demonstrated that proctoring results in an
increase in procedural success, an increase in complex
CTO PCI activity and a small increase in overall CTO
PCI activity. We believe that existing expert PCI opera-
tors wishing to undertake CTO PCI will see signiﬁcantly
better results following further formal training and, in
particular, undertaking cases jointly with a visiting
proctor in their own centre. Proctoring may be a valu-
able way to improve access to CTO PCI and the likeli-
hood of procedural success for patients.
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